Cargando…
Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy
Non-alcoholic fatty liver disease (NAFLD) is a common liver lesion that is untreatable with medications. Glucagon-like peptide-1 receptor (GLP-1R) agonists have recently emerged as a potential NAFLD pharmacotherapy. However, the molecular mechanisms underlying these drugs’ beneficial effects are not...
Autores principales: | Khalifa, Olfa, H. Mroue, Kamal, Mall, Raghvendra, Ullah, Ehsan, S. Al-Akl, Nayla, Arredouani, Abdelilah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599706/ https://www.ncbi.nlm.nih.gov/pubmed/36289914 http://dx.doi.org/10.3390/biomedicines10102652 |
Ejemplares similares
-
Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism
por: Errafii, Khaoula, et al.
Publicado: (2022) -
Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells
por: Khalifa, Olfa, et al.
Publicado: (2023) -
Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
por: Errafii, Khaoula, et al.
Publicado: (2021) -
Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway
por: Khalifa, Olfa, et al.
Publicado: (2022) -
Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers
por: Khalifa, Olfa, et al.
Publicado: (2020)